0001829126-22-018321.txt : 20221027 0001829126-22-018321.hdr.sgml : 20221027 20221027160533 ACCESSION NUMBER: 0001829126-22-018321 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220923 FILED AS OF DATE: 20221027 DATE AS OF CHANGE: 20221027 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GLAUSER STEVEN JERRY CENTRAL INDEX KEY: 0001385272 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55008 FILM NUMBER: 221337348 MAIL ADDRESS: STREET 1: 1428 BRICKELL AVENUE STREET 2: SUITE 105 CITY: MIAMI STATE: FL ZIP: 33131 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Organicell Regenerative Medicine, Inc. CENTRAL INDEX KEY: 0001557376 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS TRANSPORTATION EQUIPMENT [3790] IRS NUMBER: 474180540 STATE OF INCORPORATION: NV FISCAL YEAR END: 1031 BUSINESS ADDRESS: STREET 1: 1951 NW 7TH AVENUE STREET 2: SUITE 300 CITY: MIAMI STATE: FL ZIP: 33136 BUSINESS PHONE: 888-963-7881 MAIL ADDRESS: STREET 1: 1951 NW 7TH AVENUE STREET 2: SUITE 300 CITY: MIAMI STATE: FL ZIP: 33136 FORMER COMPANY: FORMER CONFORMED NAME: Biotech Products Services & Research, Inc. DATE OF NAME CHANGE: 20150917 FORMER COMPANY: FORMER CONFORMED NAME: BESPOKE TRICYCLES INC DATE OF NAME CHANGE: 20120831 3 1 ownership.xml FORM 3 X0206 3 2022-09-23 0 0001557376 Organicell Regenerative Medicine, Inc. OCEL 0001385272 GLAUSER STEVEN JERRY 3321 COLLEGE AVENUE, SUITE 246 DAVIE FL 333144 1 0 0 0 Common Stock, $0.001 par value 26666666 D Warrants to Purchase Common Stock 0.0441 2022-09-23 2032-09-23 Common Stock, par value $0.001 per share 1000000 D The Warrants vest in 12 monthly installments of 83,333 shares commencing on September 23, 2022. Exhibit List - Exhibit 24 Power of attorney /s/ Dale S. Bergman as attorney-in-fact for S. Jerry Glauser 2022-10-27 EX-24 2 e136710-glauser_ex24.htm EXHIBIT 24

Exhibit 24

POWER OF ATTORNEY

The undersigned constitutes and appoints Dale S. Bergman and Ian Bothwell and each of them, as the undersigned’s true and lawful attorney-in-fact and agents, with full power of substitution and resubstitution, for the undersigned and in the undersigned’s name, place and stead, to sign any and all Securities and Exchange Commission statements of beneficial ownership of securities of Organicell Regenerative Medicine, Inc. (the “Company”) on Forms 3, 4, and 5 as required under Section 16 of the Securities Exchange Act of 1934, as amended, and any amendments thereto, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, the Company and any stock exchange on which any of the Company’s securities are listed, granting unto said attorney-in-fact and agent full power and authority to do and perform each act and thing requisite and necessary to be done under said Section 16, as fully and to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent may lawfully do or cause to be done by virtue hereof.

A copy of this power of attorney shall be filed with the Securities and Exchange Commission. The authorization set forth above shall continue in full force and effect until the undersigned revokes such authorization by written instructions to the attorney-in-fact.

The authority granted hereby shall in no event be deemed to impose or create any duty on behalf of the attorney-in-fact with respect to the undersigned’s obligations to file Forms 3, 4 and 5 with the Securities and Exchange Commission.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of October 27, 2022.

	By:	/s/ S. Jerry Glauser
		Name:	S. Jerry Glauser